Anti-spike antibody responses to SARS-CoV-2 mRNA vaccines in people with schizophrenia and schizoaffective disorder

Importance: Individuals with schizophrenia are at higher risk for severe COVID-19 illness and severe breakthrough infection following vaccination. It is unclear whether immune response to vaccination differs in this population. Objective: To assess whether anti-SARS-CoV-2 spike antibody titers after...

Full description

Bibliographic Details

Published in:	Brain, Behavior, & Immunity - Health
Main Authors:	Katlyn Nemani, Livia De Picker, Faith Dickerson, Marion Leboyer, Michele Santacatterina, Fumika Ando, Gillian Capichioni, Thomas E. Smith, Jamie Kammer, Kawtar El Abdellati, Manuel Morrens, Violette Coppens, Emily Katsafanas, Andrea Origoni, Sabahat Khan, Kelly Rowe, R.Sarah Ziemann, Ryad Tamouza, Robert H. Yolken, Donald C. Goff
Format:	Article
Language:	English
Published:	Elsevier 2024-07-01
Subjects:	Schizophrenia Schizoaffective disorder COVID-19 mRNA vaccine Immunogenicity Antibody response
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666354624000802